CD8+ T cell responses against neoantigens associated with the actin cytoskeleton can lead to partial or complete tumor regression in both mice and humans (Matsushita et al., 2012; Zorn and Hercend, 1999). The gene discussed is CD8A; the disease is neoplasm.